The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. The rising incidence of cancer, technological advancements, and advantages offered by IORT are the major factors driving the growth of the global intraoperative radiation therapy market. Research and clinical trials are also being conducted to expand the applications of IORT; this will add to market growth prospects in the coming years.
Get Sample Report With Graphs and Table @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083
The technological advancements such as the introduction of mobile IORT system, rising incidence of cancer, and advantages offered by IORT over conventional radiotherapy are the major factors driving the growth of the global intraoperative radiation therapy market.
The Electron IORT segment to account for the largest share of the intraoperative radiation therapy market, by technology
Based on technology, the intraoperative radiation therapy market is segmented into electron IORT and intraoperative brachytherapy. The electron IORT segment is expected to account for the largest share of the intraoperative radiation therapy market in 2019. IOERT is a suitable option for patients with locally advanced or recurrent cancer such as partial breast and rectal cancer.
The breast cancer segment, by application, is to register the highest CAGR in the intraoperative radiation therapy market during the forecast period
Based on application, the intraoperative radiation therapy market is segmented into breast cancer, brain tumor, gastrointestinal cancer, head & neck cancer, colorectal cancer, endometrial and cervical cancer, lung cancer, and other cancers. IORT offers a reduced amount of irradiation, shorter treatment time, and lesser clinical effects on the skin, lung, and heart.
North America to dominate the intraoperative radiation therapy market during the forecast period
The intraoperative radiation therapy market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American region is expected to account for the largest share of the intraoperative radiation therapy market.
Key Market Players
The major players operating in the intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd.
This report has segmented the global Intraoperative radiation therapy market into following segments & sub-segments:
By Product & Service
- Products
- Systems/Accelerators
- Applicators & Afterloaders
- Treatment Planning Systems
- Accessories
- Services
By Technology
- Electron IORT
- Intraoperative Brachytherapy
By Application
- Breast Cancer
- Brain Tumor
- Gastrointestinal Cancer
- Head & Neck Cancer
- Colorectal Cancer
- Endometrial & Cervical Cancer
- Lung Cancer
- Other Cancers (penile cancer and prostate cancer)
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Recent Developments
- Elekta AB launched Geneva, a universal gynecological applicator for brachytherapy.
- Varian acquired Cancer Treatment Services International (CTSI), a US-based oncology solutions division that provides cancer care professional services to healthcare providers worldwide. The acquisition expanded Varian’s access to technology-driven cancer care .
- Varian launched the Bravos afterloader system for high-dose-rate (HDR) brachytherapy treatments
For More Information or Query or Customization before buying, Visit @ https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=245000083
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledgestore” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
